nodes	percent_of_prediction	percent_of_DWPC	metapath
Amprenavir—ABCB1—esophageal cancer	0.442	1	CbGaD
Amprenavir—ABCC1—Methotrexate—esophageal cancer	0.106	0.287	CbGbCtD
Amprenavir—CYP2C9—Capecitabine—esophageal cancer	0.0807	0.218	CbGbCtD
Amprenavir—CYP2B6—Cisplatin—esophageal cancer	0.0769	0.208	CbGbCtD
Amprenavir—CYP2C9—Cisplatin—esophageal cancer	0.0406	0.11	CbGbCtD
Amprenavir—ABCB1—Cisplatin—esophageal cancer	0.0394	0.107	CbGbCtD
Amprenavir—ABCB1—Methotrexate—esophageal cancer	0.0256	0.0693	CbGbCtD
Amprenavir—Amylase increased—Cisplatin—esophageal cancer	0.00173	0.0529	CcSEcCtD
Amprenavir—Paraesthesia oral—Capecitabine—esophageal cancer	0.00129	0.0396	CcSEcCtD
Amprenavir—Opportunistic infection—Methotrexate—esophageal cancer	0.00112	0.0343	CcSEcCtD
Amprenavir—Hypertriglyceridaemia—Capecitabine—esophageal cancer	0.00106	0.0323	CcSEcCtD
Amprenavir—Blood triglycerides increased—Capecitabine—esophageal cancer	0.000925	0.0283	CcSEcCtD
Amprenavir—Hyperbilirubinaemia—Capecitabine—esophageal cancer	0.000667	0.0204	CcSEcCtD
Amprenavir—Inflammation—Capecitabine—esophageal cancer	0.000625	0.0191	CcSEcCtD
Amprenavir—Aspartate aminotransferase increased—Cisplatin—esophageal cancer	0.000538	0.0165	CcSEcCtD
Amprenavir—Sleep disorder—Capecitabine—esophageal cancer	0.000508	0.0156	CcSEcCtD
Amprenavir—Diabetes mellitus—Capecitabine—esophageal cancer	0.000506	0.0155	CcSEcCtD
Amprenavir—Hyperbilirubinaemia—Methotrexate—esophageal cancer	0.000496	0.0152	CcSEcCtD
Amprenavir—Abdominal discomfort—Cisplatin—esophageal cancer	0.000495	0.0151	CcSEcCtD
Amprenavir—Inflammation—Methotrexate—esophageal cancer	0.000465	0.0142	CcSEcCtD
Amprenavir—Acute coronary syndrome—Cisplatin—esophageal cancer	0.000454	0.0139	CcSEcCtD
Amprenavir—Myocardial infarction—Cisplatin—esophageal cancer	0.000451	0.0138	CcSEcCtD
Amprenavir—Hepatobiliary disease—Cisplatin—esophageal cancer	0.000435	0.0133	CcSEcCtD
Amprenavir—Liver function test abnormal—Capecitabine—esophageal cancer	0.000406	0.0124	CcSEcCtD
Amprenavir—Connective tissue disorder—Cisplatin—esophageal cancer	0.000406	0.0124	CcSEcCtD
Amprenavir—Aspartate aminotransferase increased—Capecitabine—esophageal cancer	0.000396	0.0121	CcSEcCtD
Amprenavir—Alanine aminotransferase increased—Capecitabine—esophageal cancer	0.000388	0.0119	CcSEcCtD
Amprenavir—Cardiac disorder—Cisplatin—esophageal cancer	0.000383	0.0117	CcSEcCtD
Amprenavir—Diabetes mellitus—Methotrexate—esophageal cancer	0.000377	0.0115	CcSEcCtD
Amprenavir—Abdominal discomfort—Capecitabine—esophageal cancer	0.000365	0.0112	CcSEcCtD
Amprenavir—Malnutrition—Cisplatin—esophageal cancer	0.00036	0.011	CcSEcCtD
Amprenavir—Neutropenia—Capecitabine—esophageal cancer	0.000356	0.0109	CcSEcCtD
Amprenavir—Flatulence—Cisplatin—esophageal cancer	0.000354	0.0108	CcSEcCtD
Amprenavir—Hyperglycaemia—Capecitabine—esophageal cancer	0.000343	0.0105	CcSEcCtD
Amprenavir—Depression—Capecitabine—esophageal cancer	0.000338	0.0104	CcSEcCtD
Amprenavir—Tremor—Cisplatin—esophageal cancer	0.000337	0.0103	CcSEcCtD
Amprenavir—Stevens-Johnson syndrome—Capecitabine—esophageal cancer	0.000336	0.0103	CcSEcCtD
Amprenavir—Acute coronary syndrome—Capecitabine—esophageal cancer	0.000334	0.0102	CcSEcCtD
Amprenavir—Myocardial infarction—Capecitabine—esophageal cancer	0.000332	0.0102	CcSEcCtD
Amprenavir—Hepatobiliary disease—Capecitabine—esophageal cancer	0.000321	0.00982	CcSEcCtD
Amprenavir—Myalgia—Cisplatin—esophageal cancer	0.000306	0.00937	CcSEcCtD
Amprenavir—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—esophageal cancer	0.000304	0.00931	CcSEcCtD
Amprenavir—Liver function test abnormal—Methotrexate—esophageal cancer	0.000302	0.00926	CcSEcCtD
Amprenavir—Discomfort—Cisplatin—esophageal cancer	0.000302	0.00926	CcSEcCtD
Amprenavir—Connective tissue disorder—Capecitabine—esophageal cancer	0.000299	0.00916	CcSEcCtD
Amprenavir—Erythema multiforme—Capecitabine—esophageal cancer	0.000288	0.00881	CcSEcCtD
Amprenavir—Nervous system disorder—Cisplatin—esophageal cancer	0.000288	0.00881	CcSEcCtD
Amprenavir—Skin disorder—Cisplatin—esophageal cancer	0.000285	0.00873	CcSEcCtD
Amprenavir—Cardiac disorder—Capecitabine—esophageal cancer	0.000283	0.00865	CcSEcCtD
Amprenavir—Anorexia—Cisplatin—esophageal cancer	0.00028	0.00856	CcSEcCtD
Amprenavir—Abdominal discomfort—Methotrexate—esophageal cancer	0.000271	0.00831	CcSEcCtD
Amprenavir—Musculoskeletal discomfort—Cisplatin—esophageal cancer	0.000267	0.00819	CcSEcCtD
Amprenavir—Mental disorder—Capecitabine—esophageal cancer	0.000267	0.00817	CcSEcCtD
Amprenavir—Malnutrition—Capecitabine—esophageal cancer	0.000265	0.00811	CcSEcCtD
Amprenavir—Neutropenia—Methotrexate—esophageal cancer	0.000265	0.00811	CcSEcCtD
Amprenavir—Paraesthesia—Cisplatin—esophageal cancer	0.000263	0.00807	CcSEcCtD
Amprenavir—Flatulence—Capecitabine—esophageal cancer	0.000261	0.008	CcSEcCtD
Amprenavir—Decreased appetite—Cisplatin—esophageal cancer	0.000255	0.00781	CcSEcCtD
Amprenavir—Gastrointestinal disorder—Cisplatin—esophageal cancer	0.000253	0.00776	CcSEcCtD
Amprenavir—Depression—Methotrexate—esophageal cancer	0.000252	0.00771	CcSEcCtD
Amprenavir—Stevens-Johnson syndrome—Methotrexate—esophageal cancer	0.00025	0.00766	CcSEcCtD
Amprenavir—Tremor—Capecitabine—esophageal cancer	0.000248	0.0076	CcSEcCtD
Amprenavir—Hepatobiliary disease—Methotrexate—esophageal cancer	0.000239	0.00731	CcSEcCtD
Amprenavir—Myalgia—Capecitabine—esophageal cancer	0.000226	0.00691	CcSEcCtD
Amprenavir—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—esophageal cancer	0.000224	0.00686	CcSEcCtD
Amprenavir—Discomfort—Capecitabine—esophageal cancer	0.000223	0.00683	CcSEcCtD
Amprenavir—Erythema multiforme—Methotrexate—esophageal cancer	0.000214	0.00656	CcSEcCtD
Amprenavir—Nervous system disorder—Capecitabine—esophageal cancer	0.000212	0.00649	CcSEcCtD
Amprenavir—Asthenia—Cisplatin—esophageal cancer	0.000211	0.00645	CcSEcCtD
Amprenavir—Cardiac disorder—Methotrexate—esophageal cancer	0.00021	0.00644	CcSEcCtD
Amprenavir—Skin disorder—Capecitabine—esophageal cancer	0.00021	0.00643	CcSEcCtD
Amprenavir—Anorexia—Capecitabine—esophageal cancer	0.000206	0.00631	CcSEcCtD
Amprenavir—Diarrhoea—Cisplatin—esophageal cancer	0.000201	0.00615	CcSEcCtD
Amprenavir—Mental disorder—Methotrexate—esophageal cancer	0.000199	0.00608	CcSEcCtD
Amprenavir—Malnutrition—Methotrexate—esophageal cancer	0.000197	0.00604	CcSEcCtD
Amprenavir—Musculoskeletal discomfort—Capecitabine—esophageal cancer	0.000197	0.00603	CcSEcCtD
Amprenavir—Paraesthesia—Capecitabine—esophageal cancer	0.000194	0.00595	CcSEcCtD
Amprenavir—Decreased appetite—Capecitabine—esophageal cancer	0.000188	0.00576	CcSEcCtD
Amprenavir—Gastrointestinal disorder—Capecitabine—esophageal cancer	0.000187	0.00572	CcSEcCtD
Amprenavir—Vomiting—Cisplatin—esophageal cancer	0.000187	0.00571	CcSEcCtD
Amprenavir—Fatigue—Capecitabine—esophageal cancer	0.000186	0.00571	CcSEcCtD
Amprenavir—Rash—Cisplatin—esophageal cancer	0.000185	0.00566	CcSEcCtD
Amprenavir—Dermatitis—Cisplatin—esophageal cancer	0.000185	0.00566	CcSEcCtD
Amprenavir—Gastrointestinal pain—Capecitabine—esophageal cancer	0.000177	0.00542	CcSEcCtD
Amprenavir—Nausea—Cisplatin—esophageal cancer	0.000174	0.00534	CcSEcCtD
Amprenavir—Abdominal pain—Capecitabine—esophageal cancer	0.000171	0.00524	CcSEcCtD
Amprenavir—Myalgia—Methotrexate—esophageal cancer	0.000168	0.00514	CcSEcCtD
Amprenavir—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—esophageal cancer	0.000167	0.00511	CcSEcCtD
Amprenavir—Discomfort—Methotrexate—esophageal cancer	0.000166	0.00508	CcSEcCtD
Amprenavir—Nervous system disorder—Methotrexate—esophageal cancer	0.000158	0.00483	CcSEcCtD
Amprenavir—Skin disorder—Methotrexate—esophageal cancer	0.000156	0.00479	CcSEcCtD
Amprenavir—Asthenia—Capecitabine—esophageal cancer	0.000155	0.00475	CcSEcCtD
Amprenavir—Anorexia—Methotrexate—esophageal cancer	0.000153	0.0047	CcSEcCtD
Amprenavir—Pruritus—Capecitabine—esophageal cancer	0.000153	0.00469	CcSEcCtD
Amprenavir—Diarrhoea—Capecitabine—esophageal cancer	0.000148	0.00453	CcSEcCtD
Amprenavir—Musculoskeletal discomfort—Methotrexate—esophageal cancer	0.000147	0.00449	CcSEcCtD
Amprenavir—Paraesthesia—Methotrexate—esophageal cancer	0.000145	0.00443	CcSEcCtD
Amprenavir—Decreased appetite—Methotrexate—esophageal cancer	0.00014	0.00429	CcSEcCtD
Amprenavir—Gastrointestinal disorder—Methotrexate—esophageal cancer	0.000139	0.00426	CcSEcCtD
Amprenavir—Fatigue—Methotrexate—esophageal cancer	0.000139	0.00425	CcSEcCtD
Amprenavir—Vomiting—Capecitabine—esophageal cancer	0.000138	0.00421	CcSEcCtD
Amprenavir—Rash—Capecitabine—esophageal cancer	0.000136	0.00418	CcSEcCtD
Amprenavir—Dermatitis—Capecitabine—esophageal cancer	0.000136	0.00417	CcSEcCtD
Amprenavir—Headache—Capecitabine—esophageal cancer	0.000135	0.00415	CcSEcCtD
Amprenavir—Gastrointestinal pain—Methotrexate—esophageal cancer	0.000132	0.00403	CcSEcCtD
Amprenavir—Nausea—Capecitabine—esophageal cancer	0.000128	0.00393	CcSEcCtD
Amprenavir—Abdominal pain—Methotrexate—esophageal cancer	0.000127	0.0039	CcSEcCtD
Amprenavir—Asthenia—Methotrexate—esophageal cancer	0.000116	0.00354	CcSEcCtD
Amprenavir—Pruritus—Methotrexate—esophageal cancer	0.000114	0.00349	CcSEcCtD
Amprenavir—Diarrhoea—Methotrexate—esophageal cancer	0.00011	0.00337	CcSEcCtD
Amprenavir—Vomiting—Methotrexate—esophageal cancer	0.000102	0.00313	CcSEcCtD
Amprenavir—Rash—Methotrexate—esophageal cancer	0.000102	0.00311	CcSEcCtD
Amprenavir—Dermatitis—Methotrexate—esophageal cancer	0.000101	0.00311	CcSEcCtD
Amprenavir—Headache—Methotrexate—esophageal cancer	0.000101	0.00309	CcSEcCtD
Amprenavir—Nausea—Methotrexate—esophageal cancer	9.56e-05	0.00293	CcSEcCtD
Amprenavir—CYP2B6—Metabolism—ALDOB—esophageal cancer	3.85e-05	0.000246	CbGpPWpGaD
Amprenavir—ABCC1—Metabolism—CYP1B1—esophageal cancer	3.84e-05	0.000246	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	3.84e-05	0.000245	CbGpPWpGaD
Amprenavir—ABCC1—Disease—SMAD4—esophageal cancer	3.78e-05	0.000242	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—ALDOB—esophageal cancer	3.76e-05	0.000241	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—TYMP—esophageal cancer	3.76e-05	0.00024	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—GAPDH—esophageal cancer	3.7e-05	0.000237	CbGpPWpGaD
Amprenavir—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—esophageal cancer	3.69e-05	0.000236	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—ADH7—esophageal cancer	3.68e-05	0.000235	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—PLCE1—esophageal cancer	3.68e-05	0.000235	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—CRABP1—esophageal cancer	3.67e-05	0.000235	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—CYP26A1—esophageal cancer	3.66e-05	0.000234	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—PLCE1—esophageal cancer	3.65e-05	0.000233	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—ADH7—esophageal cancer	3.65e-05	0.000233	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—GAPDH—esophageal cancer	3.62e-05	0.000232	CbGpPWpGaD
Amprenavir—ABCC1—Metabolism—CYP19A1—esophageal cancer	3.61e-05	0.000231	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	3.61e-05	0.000231	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—CRABP1—esophageal cancer	3.59e-05	0.000229	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—ALOX15—esophageal cancer	3.56e-05	0.000228	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—ADH1B—esophageal cancer	3.51e-05	0.000224	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—GNG7—esophageal cancer	3.49e-05	0.000223	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—ADH1B—esophageal cancer	3.43e-05	0.000219	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—GNG7—esophageal cancer	3.41e-05	0.000218	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—GSTO1—esophageal cancer	3.4e-05	0.000217	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—TPI1—esophageal cancer	3.4e-05	0.000217	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—TYMP—esophageal cancer	3.35e-05	0.000214	CbGpPWpGaD
Amprenavir—ABCB1—Transmembrane transport of small molecules—HMOX1—esophageal cancer	3.35e-05	0.000214	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—BLVRB—esophageal cancer	3.33e-05	0.000213	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—SLC52A3—esophageal cancer	3.33e-05	0.000213	CbGpPWpGaD
Amprenavir—ABCC1—Metabolism—HMOX1—esophageal cancer	3.3e-05	0.000211	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—TYMP—esophageal cancer	3.27e-05	0.000209	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—ALDH2—esophageal cancer	3.27e-05	0.000209	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—CYP26A1—esophageal cancer	3.26e-05	0.000209	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—ALDOB—esophageal cancer	3.26e-05	0.000208	CbGpPWpGaD
Amprenavir—ABCC1—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	3.24e-05	0.000207	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—ADH1B—esophageal cancer	3.23e-05	0.000206	CbGpPWpGaD
Amprenavir—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—esophageal cancer	3.21e-05	0.000205	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—ADH1B—esophageal cancer	3.2e-05	0.000205	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—ALDH2—esophageal cancer	3.2e-05	0.000205	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—CYP26A1—esophageal cancer	3.18e-05	0.000204	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—ALOX15—esophageal cancer	3.18e-05	0.000203	CbGpPWpGaD
Amprenavir—ABCC1—Metabolism—ABCB1—esophageal cancer	3.17e-05	0.000202	CbGpPWpGaD
Amprenavir—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—esophageal cancer	3.14e-05	0.000201	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—GAPDH—esophageal cancer	3.14e-05	0.000201	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—GSTT1—esophageal cancer	3.11e-05	0.000199	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—CRABP1—esophageal cancer	3.11e-05	0.000199	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—ALOX15—esophageal cancer	3.1e-05	0.000198	CbGpPWpGaD
Amprenavir—ABCC1—Disease—HIF1A—esophageal cancer	3.09e-05	0.000198	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—TYMP—esophageal cancer	3.08e-05	0.000197	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—CYP2A6—esophageal cancer	3.08e-05	0.000197	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—TYMP—esophageal cancer	3.06e-05	0.000196	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—GSTT1—esophageal cancer	3.04e-05	0.000195	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—GSTO1—esophageal cancer	3.03e-05	0.000194	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—TPI1—esophageal cancer	3.03e-05	0.000194	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—CYP2A6—esophageal cancer	3.01e-05	0.000192	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—CYP26A1—esophageal cancer	3e-05	0.000192	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—CYP26A1—esophageal cancer	2.97e-05	0.00019	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—GSTO1—esophageal cancer	2.96e-05	0.000189	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—TPI1—esophageal cancer	2.96e-05	0.000189	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—GNG7—esophageal cancer	2.96e-05	0.000189	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—ALOX15—esophageal cancer	2.92e-05	0.000187	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—PTGS1—esophageal cancer	2.92e-05	0.000187	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—ENO1—esophageal cancer	2.92e-05	0.000187	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—ALDOB—esophageal cancer	2.91e-05	0.000186	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—ALOX15—esophageal cancer	2.9e-05	0.000185	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—PSME2—esophageal cancer	2.87e-05	0.000184	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—PSME1—esophageal cancer	2.87e-05	0.000184	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—ENO1—esophageal cancer	2.85e-05	0.000182	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—PTGS1—esophageal cancer	2.85e-05	0.000182	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—ALDOB—esophageal cancer	2.84e-05	0.000182	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—CA1—esophageal cancer	2.83e-05	0.000181	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—SLC10A2—esophageal cancer	2.83e-05	0.000181	CbGpPWpGaD
Amprenavir—ABCC1—Disease—NOS2—esophageal cancer	2.81e-05	0.00018	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—PSME1—esophageal cancer	2.81e-05	0.00018	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—PSME2—esophageal cancer	2.81e-05	0.00018	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—GAPDH—esophageal cancer	2.8e-05	0.000179	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—TPI1—esophageal cancer	2.79e-05	0.000178	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—GSTO1—esophageal cancer	2.79e-05	0.000178	CbGpPWpGaD
Amprenavir—ABCC1—Disease—NOTCH1—esophageal cancer	2.79e-05	0.000178	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—CRABP1—esophageal cancer	2.77e-05	0.000177	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—ALDH2—esophageal cancer	2.77e-05	0.000177	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—TPI1—esophageal cancer	2.77e-05	0.000177	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—GSTO1—esophageal cancer	2.77e-05	0.000177	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—GAPDH—esophageal cancer	2.73e-05	0.000175	CbGpPWpGaD
Amprenavir—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—esophageal cancer	2.73e-05	0.000174	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—CRABP1—esophageal cancer	2.71e-05	0.000173	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—ALDOB—esophageal cancer	2.67e-05	0.000171	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—ALDOB—esophageal cancer	2.65e-05	0.00017	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—GNG7—esophageal cancer	2.64e-05	0.000169	CbGpPWpGaD
Amprenavir—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—esophageal cancer	2.64e-05	0.000169	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—GSTT1—esophageal cancer	2.63e-05	0.000169	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—CYP2A6—esophageal cancer	2.6e-05	0.000167	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	2.59e-05	0.000166	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—CA2—esophageal cancer	2.59e-05	0.000166	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—GNG7—esophageal cancer	2.58e-05	0.000165	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—GAPDH—esophageal cancer	2.57e-05	0.000165	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—GAPDH—esophageal cancer	2.55e-05	0.000163	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—CRABP1—esophageal cancer	2.55e-05	0.000163	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—CRABP1—esophageal cancer	2.53e-05	0.000162	CbGpPWpGaD
Amprenavir—ABCC1—Disease—CREBBP—esophageal cancer	2.53e-05	0.000162	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—CYP1B1—esophageal cancer	2.48e-05	0.000159	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—ALDH2—esophageal cancer	2.47e-05	0.000158	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—ENO1—esophageal cancer	2.47e-05	0.000158	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—PTGS1—esophageal cancer	2.47e-05	0.000158	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—PSME1—esophageal cancer	2.43e-05	0.000156	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—PSME2—esophageal cancer	2.43e-05	0.000156	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—GNG7—esophageal cancer	2.43e-05	0.000155	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—CYP1B1—esophageal cancer	2.42e-05	0.000155	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—ALDH2—esophageal cancer	2.41e-05	0.000154	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—PLCE1—esophageal cancer	2.41e-05	0.000154	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—ADH7—esophageal cancer	2.41e-05	0.000154	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—GNG7—esophageal cancer	2.41e-05	0.000154	CbGpPWpGaD
Amprenavir—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	2.39e-05	0.000153	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—GSTT1—esophageal cancer	2.35e-05	0.00015	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—CYP19A1—esophageal cancer	2.33e-05	0.000149	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—CYP2A6—esophageal cancer	2.32e-05	0.000149	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	2.32e-05	0.000148	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—GSTT1—esophageal cancer	2.3e-05	0.000147	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—CYP19A1—esophageal cancer	2.28e-05	0.000146	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—ALDH2—esophageal cancer	2.27e-05	0.000145	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—CYP2A6—esophageal cancer	2.27e-05	0.000145	CbGpPWpGaD
Amprenavir—ABCC1—Disease—NOS3—esophageal cancer	2.26e-05	0.000145	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—ALDH2—esophageal cancer	2.25e-05	0.000144	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—PTGS1—esophageal cancer	2.2e-05	0.000141	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—ENO1—esophageal cancer	2.2e-05	0.000141	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—PSME2—esophageal cancer	2.17e-05	0.000139	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—PSME1—esophageal cancer	2.17e-05	0.000139	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—GSTT1—esophageal cancer	2.16e-05	0.000138	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—ENO1—esophageal cancer	2.15e-05	0.000138	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—PTGS1—esophageal cancer	2.15e-05	0.000138	CbGpPWpGaD
Amprenavir—ABCB1—Transmembrane transport of small molecules—CREBBP—esophageal cancer	2.15e-05	0.000137	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—GSTT1—esophageal cancer	2.14e-05	0.000137	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—CYP2A6—esophageal cancer	2.14e-05	0.000137	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—HMOX1—esophageal cancer	2.13e-05	0.000136	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	2.12e-05	0.000136	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—CYP2A6—esophageal cancer	2.12e-05	0.000136	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—PSME1—esophageal cancer	2.12e-05	0.000136	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—PSME2—esophageal cancer	2.12e-05	0.000136	CbGpPWpGaD
Amprenavir—ABCC1—Metabolism—CREBBP—esophageal cancer	2.12e-05	0.000135	CbGpPWpGaD
Amprenavir—ABCC1—Disease—ERBB2—esophageal cancer	2.12e-05	0.000135	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	2.11e-05	0.000135	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—ADH1B—esophageal cancer	2.11e-05	0.000135	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—CYP1B1—esophageal cancer	2.1e-05	0.000134	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—HMOX1—esophageal cancer	2.08e-05	0.000133	CbGpPWpGaD
Amprenavir—ABCC1—Disease—PTGS2—esophageal cancer	2.07e-05	0.000132	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—ABCB1—esophageal cancer	2.04e-05	0.000131	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—ENO1—esophageal cancer	2.03e-05	0.00013	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—PTGS1—esophageal cancer	2.03e-05	0.00013	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—TYMP—esophageal cancer	2.02e-05	0.000129	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—ENO1—esophageal cancer	2.01e-05	0.000129	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—PTGS1—esophageal cancer	2.01e-05	0.000129	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—PSME2—esophageal cancer	2e-05	0.000128	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—PSME1—esophageal cancer	2e-05	0.000128	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—ABCB1—esophageal cancer	2e-05	0.000128	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—PSME2—esophageal cancer	1.98e-05	0.000127	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—PSME1—esophageal cancer	1.98e-05	0.000127	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—CYP19A1—esophageal cancer	1.97e-05	0.000126	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—CYP26A1—esophageal cancer	1.96e-05	0.000125	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—ALOX15—esophageal cancer	1.91e-05	0.000122	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	1.9e-05	0.000121	CbGpPWpGaD
Amprenavir—ABCC1—Metabolism—NOS3—esophageal cancer	1.89e-05	0.000121	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—CYP1B1—esophageal cancer	1.87e-05	0.00012	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—CYP1B1—esophageal cancer	1.83e-05	0.000117	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—GSTO1—esophageal cancer	1.82e-05	0.000117	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—TPI1—esophageal cancer	1.82e-05	0.000117	CbGpPWpGaD
Amprenavir—ABCC1—Disease—CDKN1A—esophageal cancer	1.81e-05	0.000116	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—HMOX1—esophageal cancer	1.8e-05	0.000115	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	1.77e-05	0.000113	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—CYP19A1—esophageal cancer	1.76e-05	0.000113	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—ALDOB—esophageal cancer	1.75e-05	0.000112	CbGpPWpGaD
Amprenavir—ABCC1—Metabolism—PTGS2—esophageal cancer	1.73e-05	0.000111	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	1.73e-05	0.000111	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—ABCB1—esophageal cancer	1.73e-05	0.000111	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—CYP1B1—esophageal cancer	1.72e-05	0.00011	CbGpPWpGaD
Amprenavir—ABCC1—Disease—EP300—esophageal cancer	1.72e-05	0.00011	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—CYP19A1—esophageal cancer	1.72e-05	0.00011	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—CYP1B1—esophageal cancer	1.71e-05	0.000109	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—GAPDH—esophageal cancer	1.68e-05	0.000108	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—CRABP1—esophageal cancer	1.67e-05	0.000107	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—CYP19A1—esophageal cancer	1.62e-05	0.000104	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—HMOX1—esophageal cancer	1.61e-05	0.000103	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—CYP19A1—esophageal cancer	1.61e-05	0.000103	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—GNG7—esophageal cancer	1.59e-05	0.000101	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	1.58e-05	0.000101	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—HMOX1—esophageal cancer	1.57e-05	0.0001	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—ABCB1—esophageal cancer	1.54e-05	9.87e-05	CbGpPWpGaD
Amprenavir—ABCC1—Disease—MYC—esophageal cancer	1.5e-05	9.59e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—ALDH2—esophageal cancer	1.49e-05	9.51e-05	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—HMOX1—esophageal cancer	1.48e-05	9.46e-05	CbGpPWpGaD
Amprenavir—ABCC1—Disease—EGFR—esophageal cancer	1.47e-05	9.38e-05	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—HMOX1—esophageal cancer	1.47e-05	9.38e-05	CbGpPWpGaD
Amprenavir—ABCC1—Metabolism—EP300—esophageal cancer	1.44e-05	9.22e-05	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	1.44e-05	9.2e-05	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—ABCB1—esophageal cancer	1.42e-05	9.08e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—GSTT1—esophageal cancer	1.41e-05	9.04e-05	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—ABCB1—esophageal cancer	1.41e-05	9e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—CYP2A6—esophageal cancer	1.4e-05	8.94e-05	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—CREBBP—esophageal cancer	1.36e-05	8.73e-05	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—CREBBP—esophageal cancer	1.33e-05	8.53e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—PTGS1—esophageal cancer	1.33e-05	8.48e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—ENO1—esophageal cancer	1.33e-05	8.48e-05	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	1.31e-05	8.36e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—PSME1—esophageal cancer	1.31e-05	8.35e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—PSME2—esophageal cancer	1.31e-05	8.35e-05	CbGpPWpGaD
Amprenavir—ABCC1—Disease—PIK3CA—esophageal cancer	1.27e-05	8.14e-05	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—NOS3—esophageal cancer	1.22e-05	7.81e-05	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—NOS3—esophageal cancer	1.19e-05	7.64e-05	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	1.17e-05	7.46e-05	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—CREBBP—esophageal cancer	1.16e-05	7.39e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—CYP1B1—esophageal cancer	1.13e-05	7.21e-05	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—PTGS2—esophageal cancer	1.12e-05	7.15e-05	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—PTGS2—esophageal cancer	1.09e-05	6.99e-05	CbGpPWpGaD
Amprenavir—ABCC1—Metabolism—PIK3CA—esophageal cancer	1.07e-05	6.82e-05	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	1.06e-05	6.8e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—CYP19A1—esophageal cancer	1.06e-05	6.78e-05	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—NOS3—esophageal cancer	1.03e-05	6.62e-05	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—CREBBP—esophageal cancer	1.03e-05	6.6e-05	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—CREBBP—esophageal cancer	1.01e-05	6.44e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—HMOX1—esophageal cancer	9.67e-06	6.18e-05	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—CREBBP—esophageal cancer	9.49e-06	6.07e-05	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—PTGS2—esophageal cancer	9.46e-06	6.05e-05	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—CREBBP—esophageal cancer	9.4e-06	6.01e-05	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—EP300—esophageal cancer	9.29e-06	5.94e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—ABCB1—esophageal cancer	9.28e-06	5.93e-05	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—NOS3—esophageal cancer	9.23e-06	5.91e-05	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—EP300—esophageal cancer	9.08e-06	5.81e-05	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—NOS3—esophageal cancer	9.01e-06	5.76e-05	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—NOS3—esophageal cancer	8.49e-06	5.43e-05	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—PTGS2—esophageal cancer	8.44e-06	5.4e-05	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—NOS3—esophageal cancer	8.42e-06	5.38e-05	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—PTGS2—esophageal cancer	8.24e-06	5.27e-05	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—EP300—esophageal cancer	7.87e-06	5.03e-05	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—PTGS2—esophageal cancer	7.77e-06	4.97e-05	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—PTGS2—esophageal cancer	7.7e-06	4.92e-05	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—EP300—esophageal cancer	7.02e-06	4.49e-05	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—PIK3CA—esophageal cancer	6.88e-06	4.4e-05	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—EP300—esophageal cancer	6.86e-06	4.38e-05	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—PIK3CA—esophageal cancer	6.72e-06	4.3e-05	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—EP300—esophageal cancer	6.46e-06	4.13e-05	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—EP300—esophageal cancer	6.4e-06	4.1e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—CREBBP—esophageal cancer	6.2e-06	3.97e-05	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—PIK3CA—esophageal cancer	5.82e-06	3.72e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—NOS3—esophageal cancer	5.55e-06	3.55e-05	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—PIK3CA—esophageal cancer	5.2e-06	3.32e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—PTGS2—esophageal cancer	5.08e-06	3.25e-05	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—PIK3CA—esophageal cancer	5.07e-06	3.24e-05	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—PIK3CA—esophageal cancer	4.78e-06	3.06e-05	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—PIK3CA—esophageal cancer	4.74e-06	3.03e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—EP300—esophageal cancer	4.22e-06	2.7e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—PIK3CA—esophageal cancer	3.12e-06	2e-05	CbGpPWpGaD
